Whole-body MRI quantitative biomarkers are associated significantly with treatment response in patients with newly diagnosed symptomatic multiple myeloma following bortezomib induction. (2017)

First Author: Latifoltojar A

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00330-017-4907-8

PubMed Identifier: 28656463

Publication URI: http://europepmc.org/abstract/MED/28656463

Type: Journal Article/Review

Volume: 27

Parent Publication: European radiology

Issue: 12

ISSN: 0938-7994